Ph.D., Director of Pathology, Peter MacCallum Cancer Centre, Pillar Biosciences
Dr. Paul Waring is an anatomical, molecular and translational pathologist who is a pioneer in the application of molecular and genomic technologies to cancer diagnostics and cancer drug development. Dr. Waring served in various senior academic and industry positions including Director of Pathology at the Peter MacCallum Cancer Centre in Melbourne Australia, Senior Director of Pathology and Diagnostics at Genentech, USA, Chair of Pathology at the University of Melbourne, and Vice President of Medical Innovation at Roche Diagnostics USA. He has published over 140 scientific articles and abstracts, and served on numerous committees and advisory boards in the fields of cancer molecular pathology and personalized medicine. He earned an MBBS degree from the University of Western Australia, completed anatomic pathology training at the Queen Elizabeth II Medical Centre in Western Australia and a PhD in Cancer Biology from the Walter and Eliza Hall Institute at the University of Melbourne.
Clinical & Research Tools Showcase: Pillar Biosciences
Pillar Biosciences develops and manufactures targeted next-generation sequencing-based assays and software utilizing patented SLIMamp technology.
Strategies For Biomarkers To Enhance Development Of Novel Therapeutics
A discussion of the current state of precision medicine for oncology and unmet diagnostic needs.